Compare DexCom, Inc. (DXCM) vs Trip.com Group Ltd (TCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Trip.com Group Ltd — how do they compare? DexCom, Inc. trades at $83.88 (market cap $31.86B), while Trip.com Group Ltd trades at $38.88 (market cap $23.75B). The key difference: DexCom, Inc. is the larger of the two by market cap, and Trip.com Group Ltd pays a 0.42% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Trip.com Group Ltd for 79 Days on average.
| DXCM | TCOM | |
|---|---|---|
Market Cap | $31.86B | $23.75B |
Volume | 3,607,070 | 2,089,737 |
Sector | Health | Consumer Cyclical |
52-Week High | $92.34 | $78.96 |
52-Week Low | $54.84 | $37.96 |
Typical Hold Time | 62 Days | 79 Days |
Enterprise Value | $31.32B | $15.91B |
Dividend Yield | — | 0.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $84.3, up 1.09% today, with a bearish technical signal despite strong fundamentals. The company reported Q2 2026 EPS of $0.70, beating estimates, continuing a trend of earnings outperformance. Revenue growth is robust, with 2025 revenue reaching $4.66 billion and net income margin improving to 20.12%. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target, suggesting significant upside from current levels.
The outlook for DXCM is positive driven by expansion in continuous glucose monitoring for Type 2 diabetes, as highlighted in recent company reports. Key risks include competitive pressures and reimbursement challenges. With solid cash flow generation and institutional support, the stock presents a growth opportunity, though investors should monitor execution against high expectations.
Trip.com Group (TCOM) trades at $38.89, up 2.1% with mixed technical signals showing bearish moving averages but oversold RSI conditions. The company demonstrates strong fundamentals with revenue growing from $20.0B in 2022 to $62.4B in 2025, maintaining robust 36.9% net margins. Recent Q2 2026 earnings beat expectations at $1.07 per share versus $0.98 estimate, though regulatory headwinds from Chinese antitrust actions create uncertainty.
The stock presents a compelling value opportunity with low P/E of 7.34 and significant 46% upside to consensus price target of $56.64, supported by 70% analyst buy ratings. However, regulatory pressure on pricing algorithms and geopolitical risks require careful monitoring given the bearish technical setup and recent price volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →
